Xin-Hui Zhang

Xin-Hui Zhang

Auto-generated profile, based on publicly available information

Xin-Hui Zhang

Collaborative Innovation Center of New Drug Research and Safety Evaluation, Henan Province, Key Laboratory of Technology Drug Preparation (Zhengzhou University), Ministry of Education of China, Key Laboratory of Henan Province for Drug Quality and Evaluation, School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, 450001, PR China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Acta Pharmaceutica Sinica B
Verified
Journal Article
Open access
BZBing Zhao
Bing Zhao
XZXinhui Zhang
Xinhui Zhang
TYTingting Yu
Tingting Yu
YLYing Liu
Ying Liu
XZXiaoling Zhang
Xiaoling Zhang
SQShangshang Qin
Shangshang Qin
New Delhi metallo-β-lactamase-1 (NDM-1) is capable of hydrolyzing nearly all β-lactam antibiotics, posing an emerging threat to public health. There are currently less effective treatment options for treating NDM-1 positive “superbug”, and no promising NDM-1 inhibitors were used in clinical practice. In this study, structure–activity relationship based on thiosemicarbazone derivatives was systematically characterized and their potential activities combined with meropenem (MEM) were evaluated. Compounds 19bg and 19bh exhibited excellent activity against 10 NDM-positive isolate clinical isolates in reversing MEM resistance. Further studies demonstrated compounds 19bg and 19bh were uncompetitive NDM-1 inhibitors with Ki = 0.63 and 0.44 μmol/L, respectively. Molecular docking speculated that compounds 19bg and 19bh were most likely to bind in the allosteric pocket which would affect the catalytic effect of NDM-1 on the substrate meropenem. Toxicity evaluation experiment showed that no hemolysis activities even at concentrations of 1000 mg/mL against red blood cells. In vivo experimental results showed combination of MEM and compound 19bh was markedly effective in treating infections caused by NDM-1 positive strain and prolonging the survival time of sepsis mice. Our finding showed that compound 19bh might be a promising lead in developing new inhibitor to treat NDM-1 producing superbug.

1 June 2021 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
XZXin-Hui Zhang
Xin-Hui Zhang
HKHui-Qin Kang
Hui-Qin Kang
YTYuan-Yuan Tao
Yuan-Yuan Tao
YLYi-Han Li
Yi-Han Li
JZJun-Ru Zhao
Jun-Ru Zhao
LHLiu Hong-Min
Liu Hong-Min